Not medical advice. Talk to your provider before using any peptide.
Full disclaimerPeptide Schedule Research TeamReviewed Apr 20267 Citations
Teduglutide (Gattex/Revestive)33 residuesHGDGSFSDEMNTILDNLAARDFINWLIQTKITDEach bubble = one amino acid. Size = residue mass. Color = chemical class.Teduglutide (Gattex/Revestive) is the only FDA-approved GLP-2 analog for short bowel syndrome. The STEPS trial showed 63% of patients reduced parenteral nutrition needs at 24 weeks. Cost sits near $520K per year, and intestinal adaptation reverses if you stop treatment.
2,500mcg · Daily
Summary: Add 0mL BAC water to your 5mg vial. Draw to < 0.1 units on a U-100 syringe for a 2,500mcg dose. This vial will last 0 doses.
View side effects and safety warnings →
| Level | Dose / Injection | Frequency |
|---|---|---|
| Beginner | 2,500mcg | Daily |
| Moderate | 3,500mcg | Daily |
| Aggressive | 5mg | Daily |
Teduglutide is supplied as a 5 mg lyophilized vial in 30-vial kits through GATTEX REMS-certified specialty pharmacies. Reconstitute with the 0.5 mL sterile water for injection included in the kit. Do not use bacteriostatic water. Gently roll the vial; do not shake. Let it sit 30 seconds before drawing. That gives you a 10 mg/mL concentration. For a 70 kg patient at the standard 0.05 mg/kg/day dose, you need 3,500 mcg (3.5 mg), which is 0.35 mL or 35 units on a 100-unit insulin syringe. A 50 kg patient draws 25 units (2,500 mcg). A 100 kg patient uses the full vial at 50 units (5,000 mcg). The non-obvious thing beginners miss: you must use each reconstituted vial within 3 hours. There are no preservatives. Don't prepare vials ahead of time. Bedtime dosing is the community favorite because it helps you sleep through the early abdominal bloating instead of sitting with it all day. Rotate injection sites across four abdominal quadrants; mark the quadrant on the vial if it helps you track rotation.
Dosing based on Gattex/Revestive (teduglutide) FDA Prescribing Information — 12 published references.View all sources →
Cross-check your Teduglutide (Gattex/Revestive) reconstitution math with AI
Pricing updated 2026-04-09
Prices are estimates and vary by source, location, and prescription status.Full pricing breakdown →
Disclaimer: This curve is a simplified first-order exponential decay model. Actual pharmacokinetics vary based on injection site, individual metabolism, body composition, and other factors. Half-life values are approximate and based on available preclinical and clinical literature. Many research peptides lack formal human pharmacokinetic studies. This is for educational purposes only — not medical advice.
Teduglutide (Gattex/Revestive) is the only FDA-approved GLP-2 analog for short bowel syndrome. The STEPS trial showed 63% of patients reduced parenteral nutrition needs at 24 weeks. Cost sits near $520K per year, and intestinal adaptation reverses if you stop treatment.
